?s son encouraged pt to seek care, so he was brought to ED for further eval.
In ED, afebrile, HR 60s, SBP 100s (baseline 110-130s).
Hct 21, then 14 on repeat, though no interim blood loss (?
Hct 14 spurious value).
Pt being admitted to MICU for further eval & tx of GIB.
LYMPH NODES:  Exam is negative in the supraclavicular and axillary region.
Pertinent Results: [**2184-8-12**] 07:55PM BLOOD WBC-15.0*# RBC-2.35*# Hgb-6.4*# Hct-21.0*# MCV-89 MCH-27.2# MCHC-30.4*# RDW-14.0 Plt Ct-398 [**2184-8-13**] 06:28AM BLOOD WBC-14.4* RBC-3.51*# Hgb-10.3*# Hct-30.6*# MCV-87 MCH-29.2 MCHC-33.6# RDW-14.2 Plt Ct-282 [**2184-8-13**] 02:00PM BLOOD Hct-26.7* [**2184-8-14**] 03:43AM BLOOD WBC-13.2* RBC-3.57* Hgb-10.0* Hct-32.5* MCV-91 MCH-27.9 MCHC-30.7* RDW-14.5 Plt Ct-227 [**2184-8-15**] 05:58AM BLOOD WBC-11.2* RBC-3.52* Hgb-10.2* Hct-30.8* MCV-88 MCH-28.9 MCHC-33.0 RDW-14.6 Plt Ct-227 [**2184-8-16**] 05:35AM BLOOD WBC-9.3 RBC-3.57* Hgb-10.0* Hct-31.0* MCV-87 MCH-28.0 MCHC-32.3 RDW-14.7 Plt Ct-261 [**2184-8-17**] 05:15AM BLOOD WBC-9.7 RBC-3.63* Hgb-10.3* Hct-32.2* MCV-89 MCH-28.3 MCHC-31.9 RDW-14.8 Plt Ct-245 [**2184-8-18**] 09:50AM BLOOD WBC-9.3 RBC-3.59* Hgb-10.1* Hct-32.0* MCV-89 MCH-28.2 MCHC-31.7 RDW-14.8 Plt Ct-278 [**2184-8-12**] 07:55PM BLOOD PT-31.9* PTT-31.4 INR(PT)-3.3* [**2184-8-13**] 06:28AM BLOOD PT-24.4* INR(PT)-2.4* [**2184-8-13**] 02:00PM BLOOD PT-19.1* PTT-30.5 INR(PT)-1.8* [**2184-8-14**] 03:43AM BLOOD PT-17.8* PTT-36.2* INR(PT)-1.6* [**2184-8-15**] 05:58AM BLOOD PT-17.6* PTT-30.7 INR(PT)-1.6* [**2184-8-18**] 09:50AM BLOOD PT-15.3* PTT-36.4* INR(PT)-1.4* [**2184-8-12**] 07:55PM BLOOD Glucose-109* UreaN-40* Creat-1.5* Na-136 K-4.7 Cl-104 HCO3-22 AnGap-15 [**2184-8-13**] 06:28AM BLOOD Glucose-107* UreaN-33* Creat-1.3* Na-138 K-4.4 Cl-107 HCO3-20* AnGap-15 [**2184-8-15**] 05:58AM BLOOD Glucose-100 UreaN-36* Creat-2.1* Na-137 K-3.6 Cl-106 HCO3-20* AnGap-15 [**2184-8-16**] 05:35AM BLOOD Glucose-99 UreaN-32* Creat-1.8* Na-137 K-3.3 Cl-106 HCO3-21* AnGap-13 [**2184-8-18**] 09:50AM BLOOD Glucose-145* UreaN-18 Creat-1.3* Na-140 K-3.6 Cl-108 HCO3-23 AnGap-13 [**2184-8-12**] 07:55PM BLOOD CK(CPK)-51 [**2184-8-12**] 07:55PM BLOOD cTropnT-0.03* [**2184-8-13**] 06:28AM BLOOD Albumin-3.1* [**2184-8-14**] 03:43AM BLOOD PSA-107.6* [**2184-8-12**] 09:12PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG  Culture: [**8-12**] Ucx negative.
Bcx negative x2 [**8-14**] Wound Culture MRSA [**8-16**] H.pylori negative  Imaging: [**8-13**] EGD: Findings: Esophagus: Normal esophagus.
Found to have hct 21, down from low to mid-30s.
# GIB: The pt was transfused a total of 5 units pRBCs and his HCT stabalized.
Serial HCTs were followeded initial q6 hours and then less frequently.
The pt's anticoagulation was revered with Vit K and FFP pre-procedure.
An EGD was performed on [**8-13**] which was significant for Erythema, erosion and ulceration in the antrum.
Biopsies were not taken due to contact bleeding.
H.pylori serologies were drawn and were negative.
A wound culture was positive for MRSA and given the sensitivities, the cipro and nafcillin were d/c and the patient was started on Bactrim DS for a full 14 day course.
3.75 mgevery morning DILTIAZEM HCL [DILTIA XT] - 120 mg once a day SPIRONOLACTONE -  12.5 mg every evening TAMSULOSIN -  0.4 mg once daily WARFARIN -  (- 2 mg Tablet - qd, last dose [**2183-11-2**] pre angiogram  Discharge Medications: 1.
Release 24 hr Sig: One (1) Capsule, Sust.
Release 24 hr PO HS (at bedtime).
While in the ICU, you were seen by the Gastroenterologists who did an upper endoscopy which showed some erosions in the mucosa of your stomach but no active bleeding or deep ulcers.
Because your red blood cell count was low, you were given 5 units of red blood cell tranfusion.
You did not have any further bleeding or decreases in your red blood cell count and were deemed stable for discharge on [**8-18**].
A culture was done of the ulcer because of surrounding redness.
The culture grew out a bacterial MRSA.
You were taken off of your home Diltiazem and Spironolacton because of blood pressure.
You should have your blood pressure checked by the visiting nurse service and followed up with your primary doctor to address adding this medication back.
Followup Instructions: Follow-up with your new primary care provider, [**Name10 (NameIs) 39063**] [**Name8 (MD) 106250**], MD Phone:[**Telephone/Fax (1) 250**] Date/Time:[**2184-9-1**] 3:00  Follow-up with your Vascular [**Last Name (LF) 5059**], [**First Name11 (Name Pattern1) 1112**] [**Last Name (NamePattern4) 2604**], MD Phone:[**Telephone/Fax (1) 1237**] Date/Time:[**2184-9-9**] 2:30
